The BalancedInvestor Club

Drug Manufacturers General Industry Analysis

23 companies analyzed • Returns from -216.3% to +84.7%

Company List (23 Results)

View:
Sort:

Industry Performance

(23/23 companies)
2025-07-22 → 2026-07-20
Weighted Avg
+29.1%
Best
+84.7%
Worst
-216.3%
Returns Distribution
Top 5
1. AZN+84.7%2. BIIB+44.7%3. MRK+42.2%4. JNJ+39.4%5. LLY+39.0%
Bottom 5
1. MDCX-216.3%2. NSRX-101.2%3. MDCXW-91.6%4. MIRA-64.3%5. SCLXW-51.1%

AZN

+84.7%

AstraZeneca PLC ADR

BIIB

+44.7%

Biogen Inc

MRK

+42.2%

Merck & Company Inc

JNJ

+39.4%

Johnson & Johnson

LLY

+39.0%

Eli Lilly and Company

OGN

+31.8%

Organon & Co

ABBV

+30.3%

AbbVie Inc

GSK

+30.1%

GlaxoSmithKline PLC ADR

NVS

+24.7%

Novartis AG ADR

BMY

+22.6%

Bristol-Myers Squibb Company

GILD

+19.0%

Gilead Sciences Inc

AMGN

+17.5%

Amgen Inc

PFE

-1.6%

Pfizer Inc

SNY

-10.3%

Sanofi ADR

AMRN

-11.4%

Amarin Corporation PLC

SCLX

-14.6%

Scilex Holding Company

GRFS

-23.9%

Grifols SA ADR

NVO

-29.6%

Novo Nordisk A/S

SCLXW

-51.1%

Scilex Holding Company

MIRA

-64.3%

MIRA Pharmaceuticals, Inc. Common Stock

1–20 of 23
Page 1 of 2
Methodology

The Weighted Average return (+29.1%) is calculated using market capitalization as weights. This gives larger companies more influence on the average, providing a more market-representative view.

20 companies with market cap data included: AZN, BIIB, MRK, JNJ, LLY, OGN, ABBV, GSK, NVS, BMY and 10 more...

We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer